Abiopharma

Director Papapetropoulos Spyros 🟢 acquired 34.6K shares (1 derivative) of Neuphoria Therapeutics Inc. (NEUP) at $8.27 Transaction Date: Aug 27, 2025 | Filing ID: 082904

Ocugen to Participate in H.C. Wainwright 27th Annual Global Investment Conference & Biotech on Tap 2025

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s): Disclosure of Interest of substantial shareholder - CTX Treuhand Aktiengesellschaft

New Form 8-K - Voyager Therapeutics, Inc. Filed: 2025-09-02 AccNo: 0001104659-25-085977 Size: 3 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Neumora Therapeutics to Participate in Upcoming Conferences in September

Stoke Therapeutics and Biogen Present Data at the 36th International Epilepsy Congress that Support the Potential for Zorevunersen to be the First Disease-Modifying Medicine for Dravet Syndrome

FibroGen Completes Sale of FibroGen China to AstraZeneca for Approximately $220 Million

Olezarsen significantly reduces triglycerides and acute pancreatitis events in landmark pivotal studies for people with severe hypertriglyceridemia (sHTG)

Seer Appoints Isaac Ro to its Board of Directors

Adicet Bio to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Atea Pharmaceuticals to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference

Pulse Biosciences Announces First Successful Procedures in PRECISE Benign Thyroid Nodule (BTN) Study

New Form 8-K - UNITED THERAPEUTICS Corp Filed: 2025-09-02 AccNo: 0001104659-25-085976 Size: 234 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

Verrica Pharmaceuticals to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

CollPlant to Present at the 2025 International Conference on Biofabrication